U.S. drugmaker Pfizer said it would license an experimental cancer treatment from China's 3SBio Inc , paying $1.25 billion ...

Pfizer Inc. (NYSE:PFE) is navigating a period of strategic upheaval and legal scrutiny as it ends its clinical collaboration ...

Pfizer is making more changes to its marketing partnerships. According to a report from Campaign US, 2 Pfizer will now be working with Publicis for its global creative duties. IPG will still hold ...

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

This development comes at a time when global healthcare companies are intensifying their focus on innovation in key Asian markets. The opening of the R&D centre is expected to bolster Pfizer’s ...

These include the partnership with Haya Karima in ... patients’ lives in the region and beyond”. Pfizer’s recent acquisition of global biotech company Seagen marked the beginning of a ...

Pfizer's recent acquisition of global biotech company Seagen marked ... We are eager to strengthen our partnership network, leverage cutting-edge technologies, and introduce new products to ...

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry. The pharmaceutical giant will pay the smaller firm up to $350 million ...

“We do not see low-hanging fruit to boost shareholder value,” David Risinger, a Leerink Partners ... Global Market Intelligence. Trained as a veterinarian, Bourla spent much of his career at ...

These include the partnership with Haya Karima in ... change patients' lives in the region and beyond". Pfizer's recent acquisition of global biotech company Seagen marked the beginning of a ...

These include the partnership with Haya Karima in ... patients’ lives in the region and beyond.” Pfizer’s recent acquisition of global biotech company Seagen marked the beginning of a ...